-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Downgrades Zimmer Biomet Holdings to Neutral, Lowers Price Target to $100

Benzinga·12/16/2025 11:22:58
Listen to the news
Baird analyst Jeff Johnson downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Outperform to Neutral and lowers the price target from $117 to $100.